Cargando…

Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer

In this study, the use of serum thymidine kinase 1 protein (STK1p) concentration for the prognosis of the overall survival of patients with locally advanced breast cancer (n=51) following routine treatment (neoadjuvant treatment, surgery and chemotherapy) was investigated. The patients were followed...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, FEIYU, TANG, LILI, XIA, TING, HE, ELLEN, HU, GUOZHU, LI, YUAN, ZHANG, MING, ZHOU, JI, ERIKSSON, STAFFAN, SKOG, SVEN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915673/ https://www.ncbi.nlm.nih.gov/pubmed/24649267 http://dx.doi.org/10.3892/mco.2013.149

Ejemplares similares

Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1
por: Wang, Naining, et al.
Publicado: (2001)

Quaternary structures of recombinant, cellular, and serum forms of Thymidine Kinase 1 from dogs and humans
por: Hanan, Sharif, et al.
Publicado: (2012)

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
por: Fang, Yujing, et al.
Publicado: (2023)

Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis
por: Ma, Hongbo, et al.
Publicado: (2021)

Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker
por: Wang, Liya, et al.
Publicado: (2021)

Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
por: Matikas, A., et al.
Publicado: (2021)

Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma
por: Wang, Liya, et al.
Publicado: (2021)

Serum thymidine kinase in acute leukaemia.
por: Hagberg, H., et al.
Publicado: (1984)

Thymidine kinase in breast cancer.
por: Robertson, J. F., et al.
Publicado: (1990)

A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment
por: Dang, Li, et al.
Publicado: (2020)

Negative Cooperative Binding of Thymidine, Ordered Substrate Binding, and Product Release of Human Mitochondrial Thymidine Kinase 2 Explain Its Complex Kinetic Properties and Physiological Functions
por: Wang, Liya, et al.
Publicado: (2018)

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
por: Mattsson Ulfstedt, Johan, et al.
Publicado: (2021)

Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2015)

Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer
por: Tribukait, Bernhard
Publicado: (2021)

Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer
por: Toi, M, et al.
Publicado: (2004)

Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients.
por: McKenna, P. G., et al.
Publicado: (1988)

Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
por: Lundgren, Per‐Olof, et al.
Publicado: (2022)

Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer
por: Carlsson, Lena, et al.
Publicado: (2009)

Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2014)

THYMIDINE TRIPHOSPHATE SYNTHESIS IN TETRAHYMENA : I. Studies on Thymidine Kinase
por: Shoup, G. D., et al.
Publicado: (1966)

INDUCIBILITY OF THYMIDINE KINASE BY THYMIDINE AS A FUNCTION OF INTERPHASE STAGE
por: Hotta, Yasuo, et al.
Publicado: (1965)

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib
por: Bagegni, Nusayba, et al.
Publicado: (2017)

Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume
por: Tribukait, Bernhard
Publicado: (2020)

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
por: Larsson, Anna-Maria, et al.
Publicado: (2020)

A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2015)

A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma
por: Sharif, Hanan, et al.
Publicado: (2023)

3'-Amino thymidine affinity matrix for the purification of herpes simplex virus thymidine kinase.
por: Tung, P. P., et al.
Publicado: (1996)

Comparison of plasma and tissue thymidine kinase activities.
por: Calvert, R. J., et al.
Publicado: (1989)

Quaternary structure of vaccinia virus thymidine kinase
por: Black, Margaret E., et al.
Publicado: (1990)

ACQUISITION OF CHICK CYTOSOL THYMIDINE KINASE ACTIVITY BY THYMIDINE KINASE-DEFICIENT MOUSE FIBROBLAST CELLS AFTER FUSION WITH CHICK ERYTHROCYTES
por: Kit, Saul, et al.
Publicado: (1974)

Neoadjuvant and adjuvant therapy in esophageal cancer
por: Weiss, Jennifer A., et al.
Publicado: (2023)

Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay
por: Chen, Zhi Heng, et al.
Publicado: (2011)

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
por: Deng, Lili, et al.
Publicado: (2017)

Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.
por: van der Gaast, A., et al.
Publicado: (1991)

Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery
por: Wang, Xiangbin, et al.
Publicado: (2023)

Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer
por: Du, Ying-Ying, et al.
Publicado: (2016)

Retrospective natural history of thymidine kinase 2 deficiency
por: Garone, Caterina, et al.
Publicado: (2018)

Coordinate Control of S Phase Onset and Thymidine Kinase Expression
por: Knight, Glenn B., et al.
Publicado: (1989)

The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
por: Koerner, Anna S., et al.
Publicado: (2023)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ncqmfv124lnf90rhekctk00eum